Bartos, L.M.* ; Quach, S.* ; Zenatti, V.* ; Kirchleitner, S.V.* ; Blobner, J.* ; Wind-Mark, K.* ; Kolabas, Z.I. ; Ulukaya, S. ; Holzgreve, A.* ; Ruf, V.C.* ; Kunze, L.H.* ; Kunte, S.T.* ; Hoermann, L.* ; Härtel, M.* ; Park, H.E.* ; Groß, M.* ; Franzmeier, N.* ; Zatcepin, A.* ; Zounek, A.* ; Kaiser, L.* ; Riemenschneider, M.J.* ; Perneczky, R.* ; Rauchmann, B.S.* ; Stöcklein, S.* ; Ziegler, S.* ; Herms, J.* ; Ertürk, A. ; Tonn, J.C.* ; Thon, N.* ; von Baumgarten, L.* ; Prestel, M.* ; Tahirovic, S.* ; Albert, N.L.* ; Brendel, M.*
Remote neuroinflammation in newly diagnosed glioblastoma correlates with unfavorable clinical outcome.
Clin. Cancer Res. 30, 4618-4634 (2024)
PURPOSE: Current therapy strategies still provide only limited success in the treatment of glioblastoma, the most frequent primary brain tumor in adults. In addition to the characterization of the tumor microenvironment, global changes in the brain of patients with glioblastoma have been described. However, the impact and molecular signature of neuroinflammation distant of the primary tumor site have not yet been thoroughly elucidated. EXPERIMENTAL DESIGN: We performed translocator protein (TSPO)-PET in patients with newly diagnosed glioblastoma (n = 41), astrocytoma WHO grade 2 (n = 7), and healthy controls (n = 20) and compared TSPO-PET signals of the non-lesion (i.e., contralateral) hemisphere. Back-translation into syngeneic SB28 glioblastoma mice was used to characterize Pet alterations on a cellular level. Ultimately, multiplex gene expression analyses served to profile immune cells in remote brain. RESULTS: Our study revealed elevated TSPO-PET signals in contralateral hemispheres of patients with newly diagnosed glioblastoma compared to healthy controls. Contralateral TSPO was associated with persisting epileptic seizures and shorter overall survival independent of the tumor phenotype. Back-translation into syngeneic glioblastoma mice pinpointed myeloid cells as the predominant source of contralateral TSPO-PET signal increases and identified a complex immune signature characterized by myeloid cell activation and immunosuppression in distant brain regions. CONCLUSIONS: Neuroinflammation within the contralateral hemisphere can be detected with TSPO-PET imaging and associates with poor outcome in patients with newly diagnosed glioblastoma. The molecular signature of remote neuroinflammation promotes the evaluation of immunomodulatory strategies in patients with detrimental whole brain inflammation as reflected by high TSPO expression.
Altmetric
Additional Metrics?
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Corresponding Author
Keywords
Regulatory T-cells; Radioligand Binding; Pet; Expression; Macrophages; Disease; Gliomas; Marker; Growth; Cd74
Keywords plus
ISSN (print) / ISBN
1078-0432
e-ISSN
1557-3265
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 30,
Issue: 20,
Pages: 4618-4634
Article Number: ,
Supplement: ,
Series
Publisher
American Association for Cancer Research (AACR)
Publishing Place
615 Chestnut St, 17th Floor, Philadelphia, Pa 19106-4404 Usa
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Institute for Tissue Engineering and Regenerative Medicine (ITERM)
Grants
Deutsche Forschungsgemeinschaft (DFG, German Research foundation)
Else Kroener-Fresenius-Stiftung
Deutsche Forschungsgemeinschaft (DFG) under Germany's Excellence Strategy
Verein zur Foerderung von Wissenschaft und Forschung an der Medizinischen Fakultaet der LMU Muenchen (WiFoMed)
Friedrich-Baur-Stiftung
Bavarian Cancer Research Center (BZKF)
Copyright